These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 22221788)

  • 1. Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.
    Shanis D; Merideth M; Pulanic TK; Savani BN; Battiwalla M; Stratton P
    Semin Hematol; 2012 Jan; 49(1):83-93. PubMed ID: 22221788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Female genital tract chronic graft-versus-host disease: review of the literature.
    Ciavattini A; Clemente N
    Anticancer Res; 2015 Jan; 35(1):13-7. PubMed ID: 25550529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges to preventing infectious complications, decreasing re-hospitalizations, and reducing cost burden in long-term survivors after allogeneic hematopoietic stem cell transplantation.
    Fuji S; Kapp M; Einsele H
    Semin Hematol; 2012 Jan; 49(1):10-4. PubMed ID: 22221780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How can we improve life expectancy and quality of life in long-term survivors after allogeneic stem cell transplantation?
    Savani BN
    Semin Hematol; 2012 Jan; 49(1):1-3. PubMed ID: 22221778
    [No Abstract]   [Full Text] [Related]  

  • 5. Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management.
    Griffith ML; Savani BN; Boord JB
    Blood; 2010 Aug; 116(8):1197-204. PubMed ID: 20439623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ongoing graft-versus-host disease is a risk factor for azoospermia after allogeneic hematopoietic stem cell transplantation: a survey of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.
    Rovó A; Aljurf M; Chiodi S; Spinelli S; Salooja N; Sucak G; Hunter A; Kim TS; Socié G; van Lint MT; Passweg JR; Arat M; Badoglio M; Tichelli A;
    Haematologica; 2013 Mar; 98(3):339-45. PubMed ID: 22929982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
    Gifford G; Sim J; Horne A; Ma D
    Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver biopsy in the management of liver dysfunction after allogeneic hematopoietic stem-cell transplantation].
    Chen H; Huang XJ; Liu KY; Xu LP; Wang H; Liu DH; Lu J; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3062-6. PubMed ID: 16324408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of late complications of allogeneic hematopoietic stem cell transplantations.
    Atilla E; Atilla PA; Toprak SK; Demirer T
    Clin Transplant; 2017 Oct; 31(10):. PubMed ID: 28753218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens.
    Abou-Mourad YR; Lau BC; Barnett MJ; Forrest DL; Hogge DE; Nantel SH; Nevill TJ; Shepherd JD; Smith CA; Song KW; Sutherland HJ; Toze CL; Lavoie JC
    Bone Marrow Transplant; 2010 Feb; 45(2):295-302. PubMed ID: 19597425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for Hematopoietic Stem Cell Transplantation.
    Zając-Spychała O; Wachowiak J; Pieczonka A; Siewiera K; Frączkiewicz J; Kałwak K; Gorczyńska E; Chybicka A; Czyżewski K; Jachna-Sawicka K; Wysocki M; Klepacka J; Goździk J; Zaucha-Prażmo A; Kowalczyk JR; Styczyński J
    Transpl Infect Dis; 2016 Oct; 18(5):690-698. PubMed ID: 27479544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severity of acute gastrointestinal graft-vs-host disease is associated with incidence of bloodstream infection after adult allogeneic hematopoietic stem cell transplantation.
    Modi A; Rybicki L; Majhail NS; Mossad SB
    Transpl Infect Dis; 2020 Feb; 22(1):e13217. PubMed ID: 31769584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Graft-versus-host disease in the ovary potentially causes female infertility after allogeneic hematopoietic stem cell transplantation].
    Shimoji S; Hashimoto D; Teshima T
    Rinsho Ketsueki; 2017; 58(7):827-834. PubMed ID: 28781281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of anti-CD4 antibody treatment and donor lymphocyte infusion ameliorates graft-versus-host disease while preserving graft-versus-tumor effects in murine allogeneic hematopoietic stem cell transplantation.
    Ueha S; Yokochi S; Ishiwata Y; Kosugi-Kanaya M; Shono Y; Shibayama S; Ito S; Matsushima K
    Cancer Sci; 2017 Oct; 108(10):1967-1973. PubMed ID: 28787768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell transplantation: supportive care and long-term complications.
    Wingard JR; Vogelsang GB; Deeg HJ
    Hematology Am Soc Hematol Educ Program; 2002; ():422-44. PubMed ID: 12446435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cGVHD on socioeconomic outcomes in survivors with pediatric hematopoietic stem cell transplant in Japan: a cross-sectional observational study.
    Soejima T; Shiohara M; Ishida Y; Inoue M; Hayakawa A; Sato A; Kamibeppu K; Atsuta Y; Yamashita T
    Int J Hematol; 2021 Apr; 113(4):566-575. PubMed ID: 33386599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of secondary solid malignancies after allogeneic hematopoietic stem cell transplantation and preventive strategies.
    Adhikari J; Sharma P; Bhatt VR
    Future Oncol; 2015; 11(23):3175-85. PubMed ID: 26551415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
    Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
    Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What do we need to know about allogeneic hematopoietic stem cell transplant survivors?
    Clark CA; Savani M; Mohty M; Savani BN
    Bone Marrow Transplant; 2016 Aug; 51(8):1025-31. PubMed ID: 27064688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Case of Multiple Sclerosis-Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature.
    Das J; Gill A; Lo C; Chan-Lam N; Price S; Wharton SB; Jessop H; Sharrack B; Snowden JA
    Front Immunol; 2020; 11():668. PubMed ID: 32431694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.